Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Danaher Corporation (NYSE:DHR) by 24.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 443,163 shares of the conglomerate’s stock after buying an additional 87,944 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned 0.06% of Danaher Corporation worth $37,399,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in the company. Buckingham Asset Management LLC lifted its holdings in shares of Danaher Corporation by 0.4% in the second quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock worth $488,000 after buying an additional 24 shares in the last quarter. Utah Retirement Systems boosted its position in shares of Danaher Corporation by 1.3% during the second quarter. Utah Retirement Systems now owns 112,303 shares of the conglomerate’s stock worth $9,477,000 after acquiring an additional 1,400 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp boosted its position in shares of Danaher Corporation by 0.6% during the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 1,274,885 shares of the conglomerate’s stock worth $107,588,000 after acquiring an additional 8,223 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in shares of Danaher Corporation during the second quarter worth $907,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in shares of Danaher Corporation by 16.4% during the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 148,040 shares of the conglomerate’s stock worth $12,493,000 after acquiring an additional 20,809 shares during the last quarter. Hedge funds and other institutional investors own 75.68% of the company’s stock.

In other Danaher Corporation news, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 in the last three months. 12.20% of the stock is currently owned by corporate insiders.

Several equities analysts recently weighed in on DHR shares. Zacks Investment Research cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Deutsche Bank AG reiterated a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. Wells Fargo & Company initiated coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $91.98.

Shares of Danaher Corporation (DHR) opened at 86.52 on Tuesday. The company’s 50-day moving average price is $84.37 and its 200 day moving average price is $84.14. The stock has a market cap of $60.10 billion, a price-to-earnings ratio of 27.62 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.62.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the business earned $0.90 earnings per share. The business’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts predict that Danaher Corporation will post $3.95 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.65%. Danaher Corporation’s payout ratio is 17.83%.

TRADEMARK VIOLATION NOTICE: “Danaher Corporation (DHR) Stake Raised by Zurcher Kantonalbank Zurich Cantonalbank” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/03/danaher-corporation-dhr-stake-raised-by-zurcher-kantonalbank-zurich-cantonalbank.html.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.